Blood substitute being developed.
D001802:Blood Substitutes / Q000494:pharmacology / Q000627:therapeutic use*; D017277:Drug Approval; D005466:Fluorocarbons / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006842:Hydrocarbons, Brominated; D009203:Myocardial Infarction / Q000188:drug therapy; D020521:Stroke / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D001802:Blood Substitutes; D005466:Fluorocarbons; D006842:Hydrocarbons, Brominated; C003072:perflubron